SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL OMB Number: 3235-0104 Estimated average burden hours per response: 0.5

1. Name and Address of Reporting Person* Romel Lawrence A (Last) (First) (Middle) 1124 COLUMBIA STREET, SUITE 130 (Street) SEATTLE WA 98104 (City) (State) (Zip)	2. Date of Event Requiring Statement (Month/Day/Year) 08/03/2004	3. Issuer Name and Ticker or Trading Symbol XCYTE THERAPIES INC [ XCYT ]
		4. Relationship of Reporting Person(s) to Issuer (Check all applicable) Director 10% Owner X Officer (give title below) Other (specify below) VP Clinical Operations	5. If Amendment, Date of Original Filed (Month/Day/Year)
			6. Individual or Joint/Group Filing (Check Applicable Line) X Form filed by One Reporting Person Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

No securities are beneficially owned.

	By: Joanna S. Black	08/30/2004
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

        POWER OF ATTORNEY

        Know all by these presents, that the undersigned hereby constitutes and
        appoints each of Kathi Cordova and Joanna Lin Black, signing singly, the
        undersigned's true and lawful attorney-in-fact to:

        (1) execute for and on behalf of the undersigned, in the undersigned's
        capacity as an officer, director and/or 10% stockholder of
        Xcyte Therapies, Inc. (the "Company"), Forms ID, 3, 4 and 5 in
        accordance with Section 16(a) of the Securities Exchange Act of 1934
        (the "Act") and the rules thereunder, and any other forms or reports the
        undersigned may be required to file in connection with the undersigned's
        ownership, acquisition or disposition of securities of the Company;

        (2) do and perform any and all acts for and on behalf of the undersigned
        which may be necessary or desirable to complete and execute any such
        Form ID, 3, 4 or 5, or other form or report, and timely file such form
        or report with the United States Securities and Exchange Commission and
        any stock exchange or similar authority; and

        (3) take any other action of any type whatsoever in connection with the
        foregoing which, in the opinion of such attorney-in-fact, may be of
        benefit to, in the best interest of, or legally required by, the
        undersigned, it being understood that the documents executed by such
        attorney-in-fact on behalf of the undersigned pursuant to this Power of
        Attorney shall be in such form and shall contain such terms and
        conditions as such attorney-in-fact may approve in such
        attorney-in-fact's discretion.

        The undersigned hereby grants to each such attorney-in-fact full power
        and authority to do and perform any and every act and thing whatsoever
        requisite, necessary or proper to be done in the exercise of any of the
        rights and powers herein granted, as fully to all intents and purposes
        as the undersigned might or could do if personally present, with full
        power of substitution of revocation, hereby ratifying and confirming all
        that such attorney-in-fact, or such attorney-in-fact's substitute or
        substitutes, shall lawfully do or cause to be done by virtue of this
        Power of Attorney and the rights and powers herein granted.  The
        undersigned acknowledges that the foregoing attorneys-in-fact, in
        serving in such capacity at the request of the undersigned, are not
        assuming, nor is the Company assuming, any of the undersigned's
        responsibilities to comply with Section 16 of the Act.

        This Power of Attorney shall remain in full force and effect until the
        undersigned is no longer required to file Forms 3, 4 or 5 with respect
        to the undersigned's holdings of and transactions in securities issued
        by the Company, unless earlier revoked by the undersigned in a signed
        writing delivered to the foregoing attorneys-in-fact.

        IN WITNESS HEREOF, the undersigned has caused this Power of Attorney to
        be executed as of this 26th day of August, 2004.

                                                /s/ LAWRENCE A ROMEL